Rising confidence for German laser/optic components firms:
This article was originally published in Clinica
Executive Summary
German optical and laser component manufacturers are predicting average sales rises of 10% for the coming five years, a recent survey by the industry association, Spectaris, has revealed. This is the first time that the 10% expectancy figure has been surpassed. They also say that they will allocate more to R&D. Provisional information for 2004 shows an annual sales figure of E4.49bn ($5.7bn), a rise of 12.2%, for this industry branch.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.